• 10669 Citations
  • 48 h-Index
1988 …2024
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Tamara Minko is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Doxorubicin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Drug Delivery Systems Medicine & Life Sciences
Small Interfering RNA Medicine & Life Sciences
hydroxypropyl methacrylate Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
Antisense Oligonucleotides Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2003 2024

Lung Neoplasms
Non-Small Cell Lung Carcinoma
Therapeutics
Lipids
Small Interfering RNA
Nanoparticles
Neoplasms
Contrast Media
Paclitaxel
Therapeutics
Nanoparticles
Neoplasms
Paclitaxel
Contrast Media
Lung Neoplasms
Idiopathic Pulmonary Fibrosis
Nanotechnology
Pulmonary Fibrosis
Inhalation
Dinoprostone
Idiopathic Pulmonary Fibrosis
Nanotechnology
Pulmonary Fibrosis
Inhalation
Dinoprostone

Research Output 1988 2019

4 Citations (Scopus)

Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers

Garbuzenko, O. B., Kbah, N., Kuzmov, A., Pogrebnyak, N., Pozharov, V. & Minko, T., Feb 28 2019, In : Journal of Controlled Release. 296, p. 225-231 7 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Cystic Fibrosis
Inhalation
Lipids
Lung
Pharmaceutical Preparations
1 Citation (Scopus)

Nanocarrier-based systems for targeted and site specific therapeutic delivery

Majumder, J., Taratula, O. & Minko, T., Apr 1 2019, In : Advanced Drug Delivery Reviews. 144, p. 57-77 21 p.

Rutgers, The State University

Research output: Contribution to journalReview article

Pharmaceutical Preparations
Nanoparticles
Therapeutics
Modern 1601-history
Drug Carriers
Valproic Acid
Raman Spectrum Analysis
Fourier Transform Infrared Spectroscopy
Microscopy
Thermogravimetry
2 Citations (Scopus)

Prevention of paclitaxel-induced neuropathy by formulation approach

Zang, X., Lee, J. B., Deshpande, K., Garbuzenko, O. B., Minko, T. & Kagan, L., Jun 10 2019, In : Journal of Controlled Release. 303, p. 109-116 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Paclitaxel
Liposomes
Inhibitory Concentration 50
Peripheral Nervous System Diseases
Spinal Cord
Open Access
Nanotechnology
Genetic Therapy
Inhalation
Lung Neoplasms
Non-Small Cell Lung Carcinoma